KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Non-cash Items (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Non-cash Items for 11 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 0.57% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 0.57% year-over-year, with the annual reading at $1.3 million for FY2025, 0.57% up from the prior year.
  • Non-cash Items hit $1.3 million in Q4 2025 for ClearPoint Neuro, down from $21.2 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $21.2 million in Q3 2025 to a low of $1.3 million in Q4 2024.
  • Historically, Non-cash Items has averaged $7.3 million across 3 years, with a median of $1.5 million in 2021.
  • Biggest five-year swings in Non-cash Items: soared 1472.08% in 2021 and later rose 0.57% in 2025.
  • Year by year, Non-cash Items stood at $15.3 million in 2021, then crashed by 91.83% to $1.3 million in 2024, then grew by 0.57% to $1.3 million in 2025.
  • Business Quant data shows Non-cash Items for CLPT at $1.3 million in Q4 2025, $21.2 million in Q3 2025, and $1.3 million in Q2 2025.